Cargando…
Factors affecting responses to murine oncogenic viral infections.
Silica specifically kills macrophages in vitro, and in vivo has been used as a method of determining the possible immunological or other roles of macrophages in a number of viral infections. In experiments reported here, injection of 30 or 50 mg silica i.p. increased the severity of the oncogenic ef...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1980
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010292/ https://www.ncbi.nlm.nih.gov/pubmed/6248095 |
_version_ | 1782136291326951424 |
---|---|
author | Harvey, J. J. Rager-Zisman, B. Wheelock, E. F. Nevin, P. A. |
author_facet | Harvey, J. J. Rager-Zisman, B. Wheelock, E. F. Nevin, P. A. |
author_sort | Harvey, J. J. |
collection | PubMed |
description | Silica specifically kills macrophages in vitro, and in vivo has been used as a method of determining the possible immunological or other roles of macrophages in a number of viral infections. In experiments reported here, injection of 30 or 50 mg silica i.p. increased the severity of the oncogenic effects of the murine sarcoma virus (MSV) and Friend virus (FV) in BALB/c mice. Unlike Herpes simplex and Coxsackie B-3 infections, however, passive transfer of adult macrophages to suckling mice did not protect the latter against MSV. In mice injected with silica, histological evidence of the compensatory proliferation of macrophages suggests that precursors of these cells may act as target cells for the virus and that this may override any immunosuppressive response effected by the silica. In addition, there was a considerable enhancing effect on the erythroproliferative response to both MSV and FV by injection of saline 5 h before the virus, and indeed to FV after only a simple abdominal needle puncture. We attributed this to the lymphopenic immunodepressive effects of stress, and our data may explain previously published findings of augmented oncogenic responses in mice after "normal" serum injections. Newborn BALB/c (FV-1b) mice were susceptible to N-tropic FV, but developed resistance by 29 days of age. Antithymocyte serum (ATS) but not silica injections or adult thymectomy ablated this resistance. C57BL (FV-2r) mice were completely resistant to FV; however, those receiving FV and ATS developed late-onset leukaemia histologically characteristic of that produced by the helper component of the FV complex. IMAGES: |
format | Text |
id | pubmed-2010292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1980 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20102922009-09-10 Factors affecting responses to murine oncogenic viral infections. Harvey, J. J. Rager-Zisman, B. Wheelock, E. F. Nevin, P. A. Br J Cancer Research Article Silica specifically kills macrophages in vitro, and in vivo has been used as a method of determining the possible immunological or other roles of macrophages in a number of viral infections. In experiments reported here, injection of 30 or 50 mg silica i.p. increased the severity of the oncogenic effects of the murine sarcoma virus (MSV) and Friend virus (FV) in BALB/c mice. Unlike Herpes simplex and Coxsackie B-3 infections, however, passive transfer of adult macrophages to suckling mice did not protect the latter against MSV. In mice injected with silica, histological evidence of the compensatory proliferation of macrophages suggests that precursors of these cells may act as target cells for the virus and that this may override any immunosuppressive response effected by the silica. In addition, there was a considerable enhancing effect on the erythroproliferative response to both MSV and FV by injection of saline 5 h before the virus, and indeed to FV after only a simple abdominal needle puncture. We attributed this to the lymphopenic immunodepressive effects of stress, and our data may explain previously published findings of augmented oncogenic responses in mice after "normal" serum injections. Newborn BALB/c (FV-1b) mice were susceptible to N-tropic FV, but developed resistance by 29 days of age. Antithymocyte serum (ATS) but not silica injections or adult thymectomy ablated this resistance. C57BL (FV-2r) mice were completely resistant to FV; however, those receiving FV and ATS developed late-onset leukaemia histologically characteristic of that produced by the helper component of the FV complex. IMAGES: Nature Publishing Group 1980-04 /pmc/articles/PMC2010292/ /pubmed/6248095 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Harvey, J. J. Rager-Zisman, B. Wheelock, E. F. Nevin, P. A. Factors affecting responses to murine oncogenic viral infections. |
title | Factors affecting responses to murine oncogenic viral infections. |
title_full | Factors affecting responses to murine oncogenic viral infections. |
title_fullStr | Factors affecting responses to murine oncogenic viral infections. |
title_full_unstemmed | Factors affecting responses to murine oncogenic viral infections. |
title_short | Factors affecting responses to murine oncogenic viral infections. |
title_sort | factors affecting responses to murine oncogenic viral infections. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010292/ https://www.ncbi.nlm.nih.gov/pubmed/6248095 |
work_keys_str_mv | AT harveyjj factorsaffectingresponsestomurineoncogenicviralinfections AT ragerzismanb factorsaffectingresponsestomurineoncogenicviralinfections AT wheelockef factorsaffectingresponsestomurineoncogenicviralinfections AT nevinpa factorsaffectingresponsestomurineoncogenicviralinfections |